LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 XMD16-144
0.12
uM
LJP5
 0.5485 0.0740 0.4041 0.1037
BT-20 XMD16-144
0.37
uM
LJP5
 0.3555 0.0142 0.0933 0.0426
BT-20 XMD16-144
1.11
uM
LJP5
 0.3335 0.0232 0.0521 0.0693
BT-20 XMD16-144
3.33
uM
LJP5
 0.3310 0.0151 0.0487 0.0531
BT-20 XMD16-144
10
uM
LJP5
 0.2669 0.0351 -0.0790 0.0951
BT-20 Erlotinib
0.04
uM
LJP5
 0.8841 0.0148 0.8614 0.0145
BT-20 Erlotinib
0.12
uM
LJP5
 0.8972 0.0262 0.8792 0.0282
BT-20 Erlotinib
0.37
uM
LJP5
 0.9154 0.0346 0.9016 0.0390
BT-20 Erlotinib
1.11
uM
LJP5
 0.8609 0.0184 0.8336 0.0183
BT-20 Erlotinib
3.33
uM
LJP5
 0.8783 0.0269 0.8559 0.0285
BT-20 Erlotinib
10
uM
LJP5
 0.6454 0.0150 0.5474 0.0330
BT-20 Gefitinib
0.04
uM
LJP6
 1.0323 0.0365 1.0401 0.0436
BT-20 Gefitinib
0.12
uM
LJP6
 0.9723 0.0523 0.9684 0.0625
BT-20 Gefitinib
0.37
uM
LJP6
 0.9494 0.0257 0.9396 0.0296
BT-20 Gefitinib
1.11
uM
LJP6
 0.9247 0.0369 0.9094 0.0433
BT-20 Gefitinib
3.33
uM
LJP6
 0.8996 0.0260 0.8780 0.0288
BT-20 Gefitinib
10
uM
LJP6
 0.8083 0.0556 0.7617 0.0660
BT-20 Nilotinib
0.04
uM
LJP5
 1.0030 0.0220 1.0031 0.0251
BT-20 Nilotinib
0.12
uM
LJP5
 1.0098 0.0223 1.0110 0.0252
BT-20 Nilotinib
0.37
uM
LJP5
 1.0151 0.0182 1.0187 0.0226
BT-20 Nilotinib
1.11
uM
LJP5
 0.9957 0.0210 0.9956 0.0248
BT-20 Nilotinib
3.33
uM
LJP5
 1.0015 0.0188 1.0031 0.0226
BT-20 Nilotinib
10
uM
LJP5
 0.3153 0.0286 0.0181 0.0569
BT-20 JNK-9L
0.04
uM
LJP6
 0.8493 0.0247 0.8139 0.0262
BT-20 JNK-9L
0.12
uM
LJP6
 0.8341 0.0456 0.7952 0.0541